• Home
  • Biocon Biologics

BIOCON BIOLOGICS

Biocon Biologics Gets Approval From European Medicines Agency To Manufacture Cancer Drug in India
Health & Wellness

Biocon Biologics Gets Approval From European Medicines Agency To Manufacture Cancer Drug in India
Biocon Biologics to Acquire Viatris' Biosimilars Assets for Up to USD 3.335 Billion in Stock and Cash
Agency News

Biocon Biologics to Acquire Viatris' Biosimilars Assets for Up to USD 3.335 Billion in Stock and Cash
ADG20: Biocon Biologics Gets Licence from US-Based Adagio Therapeutics for Antibody Treatment of COVID-19
Agency News

ADG20: Biocon Biologics Gets Licence from US-Based Adagio Therapeutics for Antibody Treatment of COVID-19
Tata Capital Growth Fund to Invest Rs 225 Crore in Global Biopharmaceuticals Company Biocon Biologics
Agency News

Tata Capital Growth Fund to Invest Rs 225 Crore in Global Biopharmaceuticals Company Biocon Biologics
Latest News | Biocon Gets DCGI Nod for Device to Treat Critical COVID-19 Patients
Agency News

Latest News | Biocon Gets DCGI Nod for Device to Treat Critical COVID-19 Patients

Short Videos
Google Trends Google Trends
pseb
500+K+ searches
england vs australia
200000+K+ searches
dream11
2000+K+ searches
justice swaminathan
2000+K+ searches
इंगलैंड बनाम ऑस्ट्रेलिया
2000+K+ searches
Today's Trends

Editor's Choice

Trending Topics
The Summer I Turned PrettySharad Navratri 2025Fact CheckShah Rukh KhanDonald TrumpViral VideosAsia Cup 2025Bigg Boss 19Rahul GandhiWeather Forecast TodayNarendra ModiBihar Assembly Elections 2025Kerala Lottery Results
Close